This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Revisiting Some Fast Movers

Editor's Note: This was originally published as an alert at 8:55 a.m. EST on Dec. 15 to subscribers of TheStreet.com's Stocks Under $10. The stock prices and returns have been updated to reflect today's levels.

It has been one week since we put together a basket of low-dollar stocks that we believed could soar into year-end. We want to give you readers an update on how those stocks have performed and what action we would be taking here if we had added the stocks to our model portfolio. (We didn't take action, because we had 16 positions at the time.)

Here is how the five stocks have done since we wrote on them last Wednesday:

  • StemCells (STEM - Get Report) has climbed 10% to $3.28.
  • Aphton (APHT) is 10 cents lower at $3.12.
  • E-Loan (EELN) has climbed 20% to a recent $3.41.
  • Tut Systems (TUTS) is up more than 9% at $4.09.
  • OpenTV (OPTV), a model portfolio stock, has stayed about even.

    If you bought one share of each stock, you would be up 6% on your investment. As we noted in an alert last Friday afternoon, we would urge readers to be prudent and take some gains off the table when the opportunity presents itself.

    We already suggested moving out of some E-Loan for a 27% gain, and would take more off the table into today's strength. The 17% gain last Wednesday was driven by news that Capital One (COF) is making yet another acquisition in the online mortgage space. As we said initially, E-Loan is still cheap relative to the recent takeout prices, and the stock could trade closer to $4.50 a share before this run is over.

    While it may seem counterintuitive to sell speculative, volatile stocks like these into the first round of strength, look no further than our biotech pick Aphton for validation of this method. We suggested trimming positions in this name on Dec. 10, when the stock was closer to $3.90 a share. The stock has pulled all the way back since then, but the risk to performance was reduced with the smaller position.

    We continue to believe catalysts loom for interactive TV play OpenTV, digital video enabler Tut Systems and regenerative stem-cell play StemCells. We would continue holding these names, because investors still feel the need to chase small-cap stocks.

    P.S. Remember, stocks priced under $10 have the potential to move quickly. So, you might want to get our current recommendations now with a free trial to TheStreet.com Stocks Under $10.

    William Gabrielski is a research associate at TheStreet.com and is accredited with a Series 7 license. In keeping with TSC's editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Gabrielski welcomes your feedback and invites you to send your comments to william.gabrielski@thestreet.com.

    Interested in more writings from William Gabrielski? Check out Stocks Under $10. For more information, click here.

    David Peltier is a research associate at TheStreet.com In keeping with TSC's editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Peltier welcomes your feedback and invites you to send your comments to david.peltier@thestreet.com.

    Check Out Our Best Services for Investors

    Action Alerts PLUS

    Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    Quant Ratings

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    Stocks Under $10

    David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    14-Days Free
    Try it NOW
    Only $9.95
    Try it NOW
    14-Days Free
    Try it NOW

    Check Out Our Best Services for Investors

    Dividend Stock Advisor

    David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Updates with exact steps to take - BUY, HOLD, SELL
    Trifecta Stocks

    Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

    Product Features:
    • Model Portfolio
    • Intra Day Trade alerts
    • Access to Quant Ratings
    Options Profits

    Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

    Product Features:
    • Actionable options commentary and news
    • Real-time trading community
    Try it NOW
    Try it NOW
    Try it NOW
    To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
    Submit an article to us!
    SYM TRADE IT LAST %CHG
    STEM $0.99 0.00%
    AAPL $123.25 0.00%
    FB $83.30 0.00%
    GOOG $548.34 0.00%
    TSLA $185.00 0.00%

    Markets

    DOW 17,712.66 +34.43 0.19%
    S&P 500 2,061.02 +4.87 0.24%
    NASDAQ 4,891.2190 +27.8570 0.57%

    Partners Compare Online Brokers

    Free Reports

    Free Newsletters from TheStreet

    My Subscriptions:

    After the Bell

    Before the Bell

    Booyah! Newsletter

    Midday Bell

    TheStreet Top 10 Stories

    Winners & Losers

    Register for Newsletters
    Top Rated Stocks Top Rated Funds Top Rated ETFs